Baidu
map

药学类自然科学基金样本

2009-02-22 MedSci原创 MedSci原创

药学类.rar

药学类.rar

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (26)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2014-11-01 joeyliu0121

    谢谢分享的资料,正用上!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2012-03-13 rafeek

    I can already tell that's gonna be super hlepful.

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2011-09-05 ywl75851124

    非常感谢楼主,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2011-05-28 pingzi627

    救我之所急,多谢了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2011-02-18 limingchou

    thanks

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2011-02-06 sunyq0825@yaho

    医院药局如何找寻自然科学基金项目

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2011-01-23 solardoc

    非常感謝楼主的无私分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2010-12-18 tzyy6644

    正找呢,谢谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2010-07-02 shiqingwen

    需要药学类自然科学基金样本,请提供,谢谢。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=12389, encodeId=0c2e1238925, content=谢谢分享的资料,正用上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e37109474, createdName=joeyliu0121, createdTime=Sat Nov 01 09:39:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4107, encodeId=7a1c410ef6, content=I can already tell that's gonna be super hlepful., beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rafeek, createdTime=Tue Mar 13 15:37:00 CST 2012, time=2012-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2927, encodeId=152e292e30, content=非常感谢楼主,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b1445318, createdName=ywl75851124, createdTime=Mon Sep 05 21:27:00 CST 2011, time=2011-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2311, encodeId=f47023119c, content=救我之所急,多谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08df39136, createdName=pingzi627, createdTime=Sat May 28 12:29:00 CST 2011, time=2011-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039, encodeId=a02a203976, content=thanks, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b1f32738, createdName=limingchou, createdTime=Fri Feb 18 14:52:00 CST 2011, time=2011-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008, encodeId=126f200870, content=医院药局如何找寻自然科学基金项目, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ea832172, createdName=sunyq0825@yaho, createdTime=Sun Feb 06 10:11:00 CST 2011, time=2011-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989, encodeId=be541989a6, content=非常感謝楼主的无私分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb431738, createdName=solardoc, createdTime=Sun Jan 23 21:53:00 CST 2011, time=2011-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1888, encodeId=fbfe1888dc, content=正找呢,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f82b29398, createdName=tzyy6644, createdTime=Sat Dec 18 16:49:00 CST 2010, time=2010-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418, encodeId=ceac141826, content=需要药学类自然科学基金样本,请提供,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05821193, createdName=shiqingwen, createdTime=Fri Jul 02 09:58:00 CST 2010, time=2010-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401, encodeId=5cdb140175, content=特有用,谢谢啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=255e20914, createdName=liuping301, createdTime=Mon Jun 28 09:32:00 CST 2010, time=2010-06-28, status=1, ipAttribution=)]
    2010-06-28 liuping301

    特有用,谢谢啊

    0

相关资讯

基金申请指南与技巧谈

我们MedSci的相关人员曾经参与国内的863攀登计划项目,973的干细胞专项,自然科学基金自然不用说了,主写的就不少。973是主写之一,863是参与项目,子项目吧。同时,也成功申请美国NIH诸多基金的支持。另外,我们曾经与973项目的多个核心评委沟通过。我们团队成员有是江苏省无锡市海外高科技引进人才。 相对来说,还是比

获取国家基金支持的十大法则(转自生物谷)

规则一:有新颖性,但忌太过标新立异好科学源于新的思想。基金撰写过程应该是一件快乐的事情,因为你可以向阅读你基金报告的同行清楚的表述你的新思想。把撰写基金计划书看作产生影响的机会。要对你所写的内容充满热情,如果你对自己的工作缺乏热情,就未必能写出好的报告,也不大可能获得资助。模仿性科学(“Me-too” Science)一般难以获得资助。另一方面,太过冥想性的科学也难以获得资助,特别当基金紧张时。尽

医学类自然科学基金样本(11份)

医学类自然科学基金样本.rar 一共11份自然科学基金样本,供参考与学习

2008国家自然科学基金资助项目统计资料(NSFC发布).

2008国家自然科学基金资助项目统计资料(NSFC发布).pdf 通过这里可以了解到每年自然科学基金的分布规律

如何撰写标书提高国家自然科学基金中标率

如何撰写标书提高国家自然科学基金中标率.rar

2009年国家自然科学基金申请书的撰写及注意

国家自然科学基金申请书的撰写及注意2009.rar

Baidu
map
Baidu
map
Baidu
map